CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Abbisko Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 28, 2024N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof1

Top competitors of Abbisko Therapeutics

Top competitors of Abbisko Therapeutics based on patent oppositions.